Solesence (SLSN) Common Equity (2010 - 2026)

Solesence (SLSN) has reported Common Equity for 17 consecutive years, with $13.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity fell 8.8% year-over-year to $13.2 million; the trailing twelve-month figure through Jun 2026 stood at $13.2 million (down 8.8% YoY), and the FY2025 full-year result was $14.1 million, up 36.06% from the prior year.
• Common Equity declined to $13.2 million in Q2 2026 per SLSN's latest filing, from $13.2 million in the prior quarter.
• Across five years, Common Equity topped out at $17.2 million in Q3 2025 and bottomed at $1.9 million in Q4 2023.
• Historically, Common Equity has averaged $9.4 million across 5 years, with a median of $9.2 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Common Equity sank 66.33% in 2023, then jumped 444.32% in 2024.
• Over 5 years, Common Equity stood at $5.6 million in 2022, then plunged by 66.33% to $1.9 million in 2023, then surged by 444.32% to $10.4 million in 2024, then jumped by 36.06% to $14.1 million in 2025, then fell by 6.62% to $13.2 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $13.2 million, $13.2 million, and $14.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.